Clinical Trial: Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT04821778) titled 'Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer' on March 15.

Brief Summary: Definitive chemoradiotherapy is the standard of care in unresectable esophageal or esophagogastric cancer. A multidisciplinary approach, including chemotherapy and radiotherapy, is important for these patients. Morerover, molecular targeting agents does not show clear efficacy in EC up to now. Nowadays, the pace of development of cancer immunotherapies is accelerating. Clinical evidence of the efficacy of immune checkpoint inhibitors and adoptive immunotherapies herald the onset of a new era in cancer immunotherapy. There have also been ...